Physician profile
Peter B Blessey
NPI 1467488163
$3,157.88
in general payments reported to CMS, 2019-2025
17 companies · $940 in 2025
The $940 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $1,470 · 2021: $64.60 · 2022: $79.28 · 2023: $189 · 2024: $183 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687 · Travel and Lodging: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.57 |
| Travel and Lodging | $625.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $1,357.93 | 2020-2023 | |
| Zimmer Biomet Holdings, INC. | $823.61 | 2025 | Oxford |
| Stryker Corporation | $225.85 | 2020-2024 | Aequalis Perform, Insignia |
| Pacira Therapeutics, INC. | $158.18 | 2019 | |
| Vericel Corporation | $118.76 | 2021-2023 | Maci |
| Orthalign INC | $79.28 | 2022 | |
| Siemens Medical Solutions USA, INC. | $66.26 | 2024 | Acuson Sequoia Diagnostic Ultrasound System, Acuson Freestyle Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System |
| Pacira Pharmaceuticals Incorporated | $57.95 | 2020-2023 | Zilretta, Exparel, Iovera |
| Omnilife Science, INC | $45.98 | 2019 | |
| Innovation Technologies INC | $36.53 | 2025 | Irrisept |
| Smith+Nephew, INC. | $34.43 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Bioventus LLC | $32.08 | 2024 | Durolane |
| Microport Orthopedics INC | $27.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.42 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $23.48 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $23.23 | 2024 | Zynrelef |
| Sanara Medtech INC. | $21.48 | 2025 | Biasurge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Blessey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.